• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

管制价格下的医院竞争:在中国城市医疗卫生部门改革中的应用

Hospital competition under regulated prices: application to urban health sector reforms in China.

作者信息

Eggleston Karen, Yip Winnie

机构信息

Department of Economics, Tufts University, Braker Hall, Medford, MA 02155, USA.

出版信息

Int J Health Care Finance Econ. 2004 Dec;4(4):343-68. doi: 10.1023/B:IHFE.0000043762.33274.4f.

DOI:10.1023/B:IHFE.0000043762.33274.4f
PMID:15467409
Abstract

We develop a model of public-private hospital competition under regulated prices, recognizing that hospitals are multi-service firms and that equilibria depend on the interactions of patients, hospital administrators, and physicians. We then use data from China to calibrate a simulation model of the impact of China's recent payment and organizational reforms on cost, quality and access. Both the analytic and simulation results show how providing implicit insurance through distorted prices leads to over/under use of services by profitability, which in turn fuels cost escalation and reduces access for those who cannot afford to self-pay for care. Simulations reveal the benefits of mixed payment and expanded insurance cover for mitigating these distortions.

摘要

我们构建了一个在价格管制下的公私医院竞争模型,认识到医院是提供多种服务的企业,且均衡取决于患者、医院管理人员和医生之间的相互作用。然后,我们利用来自中国的数据校准了一个模拟模型,以评估中国近期支付和组织改革对成本、质量和就医机会的影响。分析和模拟结果均表明,通过扭曲价格提供隐性保险如何导致按盈利能力过度/不足使用服务,进而推动成本上升,并减少那些无力自费就医者的就医机会。模拟结果揭示了混合支付和扩大保险覆盖范围在减轻这些扭曲方面的益处。

相似文献

1
Hospital competition under regulated prices: application to urban health sector reforms in China.管制价格下的医院竞争:在中国城市医疗卫生部门改革中的应用
Int J Health Care Finance Econ. 2004 Dec;4(4):343-68. doi: 10.1023/B:IHFE.0000043762.33274.4f.
2
Markets for hospital services in Zambia.赞比亚的医院服务市场。
Int J Health Plann Manage. 2002 Jul-Sep;17(3):229-47. doi: 10.1002/hpm.673.
3
Reimbursement of hospital services and hospital financing.医院服务报销与医院融资。
Dev Health Econ Public Policy. 1998;7:137-60. doi: 10.1007/978-1-4615-4052-6_7.
4
Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, China.利用支付激励措施应对政府和市场失灵:中国海南的医院报销改革
Soc Sci Med. 2004 Jan;58(2):267-77. doi: 10.1016/s0277-9536(03)00010-8.
5
Competition among Turkish hospitals and its effect on hospital efficiency and service quality.土耳其医院之间的竞争及其对医院效率和服务质量的影响。
J Health Care Finance. 2013 Winter;40(2):42-58.
6
The market reform of the New Zealand health care system searching for the Holy Grail in the Antipodes.新西兰医疗体系的市场改革:在新西兰寻找圣杯。
Health Policy. 1994 Mar;27(3):233-52. doi: 10.1016/0168-8510(94)90118-x.
7
Estimating technical efficiency of Turkish hospitals: implications for hospital reform initiatives.评估土耳其医院的技术效率:对医院改革举措的启示
BMC Health Serv Res. 2018 Jun 4;18(1):401. doi: 10.1186/s12913-018-3239-y.
8
Private care and public waiting.私立医疗与公立医疗等待期
Aust Health Rev. 2005 Feb;29(1):87-93. doi: 10.1071/ah050087.
9
Health services pricing in Turkey.土耳其的医疗服务定价
Health Mark Q. 2000;17(4):21-36. doi: 10.1300/J026v17n04_02.
10
Competition policy for health care provision in France.法国医疗保健服务的竞争政策。
Health Policy. 2017 Feb;121(2):111-118. doi: 10.1016/j.healthpol.2016.11.015. Epub 2016 Nov 24.

引用本文的文献

1
Healthcare Sector Dynamics in Turkey (2002-2022): Trends, Breakpoints, and Policy Implications (Privatization in the Hospital Sector).土耳其医疗保健行业动态(2002 - 2022):趋势、转折点及政策影响(医院部门的私有化)
Healthcare (Basel). 2025 Mar 13;13(6):622. doi: 10.3390/healthcare13060622.
2
Medical service pricing and pharmaceutical supply chain coordination contracts under the zero-markup drug policy.零差价药品政策下的医疗服务定价和医药供应链协调合同。
Front Public Health. 2023 Oct 19;11:1208994. doi: 10.3389/fpubh.2023.1208994. eCollection 2023.
3
Impacts of the medical arms race on medical expenses: a public hospital-based study in Shenzhen, China, during 2009-2013.

本文引用的文献

1
Choice and solidarity: the health sector in Eastern Europe and proposals for reform.选择与团结:东欧的卫生部门及改革建议
Int J Health Care Finance Econ. 2001 Mar;1(1):59-84. doi: 10.1023/a:1011504122300.
2
Reforming China's urban health insurance system.改革中国的城市医疗保险制度。
Health Policy. 2002 May;60(2):133-50. doi: 10.1016/s0168-8510(01)00207-x.
3
Provider payment reform in China: the case of hospital reimbursement in Hainan province.中国的医疗服务提供者支付改革:以海南省医院报销为例。
医疗军备竞赛对医疗费用的影响:一项基于中国深圳公立医院的2009 - 2013年研究。
Cost Eff Resour Alloc. 2022 Dec 26;20(1):73. doi: 10.1186/s12962-022-00407-7.
4
Deregulation and pricing of medical services: a policy experiment based in China.医疗服务去监管化和定价:基于中国的一项政策实验。
BMC Health Serv Res. 2021 May 25;21(1):501. doi: 10.1186/s12913-021-06525-x.
5
Does hospital competition lead to medical equipment expansion? Evidence on the medical arms race.医院竞争是否会导致医疗设备扩张?医疗军备竞赛的证据。
Health Care Manag Sci. 2021 Sep;24(3):582-596. doi: 10.1007/s10729-020-09529-x. Epub 2021 Jan 7.
6
From plan to market in the health sector?: China's experience.从规划到医疗领域的市场化?:中国的经验
J Asian Econ. 2008 Nov-Dec;19(5):400-412. doi: 10.1016/j.asieco.2008.09.002. Epub 2008 Sep 7.
7
Did expansion of health insurance coverage reduce horizontal inequity in healthcare finance? A decomposition analysis for China.医疗保险覆盖范围的扩大是否降低了医疗保健筹资的横向不公平?来自中国的分解分析。
BMJ Open. 2019 Jan 9;9(1):e025184. doi: 10.1136/bmjopen-2018-025184.
8
Main drivers of health expenditure growth in China: a decomposition analysis.中国卫生支出增长的主要驱动因素:分解分析
BMC Health Serv Res. 2017 Mar 9;17(1):185. doi: 10.1186/s12913-017-2119-1.
9
Addressing Antibiotic Abuse in China: An Experimental Audit Study.应对中国的抗生素滥用问题:一项实验性审计研究
J Dev Econ. 2014 Sep 1;110:39-51. doi: 10.1016/j.jdeveco.2014.05.006.
10
Social Networks and Externalities from Gift Exchange: Evidence from A Field Experiment.社交网络与礼物交换的外部性:来自一项实地实验的证据。
J Public Econ. 2013 Nov 1;107:19-30. doi: 10.1016/j.jpubeco.2013.08.003.
Health Econ. 2001 Jun;10(4):325-39. doi: 10.1002/hec.602.
4
Measuring adverse selection in managed health care.衡量管理式医疗保健中的逆向选择。
J Health Econ. 2000 Nov;19(6):829-54. doi: 10.1016/s0167-6296(00)00059-x.
5
The Chinese experience of hospital price regulation.中国医院价格监管的经验。
Health Policy Plan. 2000 Jun;15(2):157-63. doi: 10.1093/heapol/15.2.157.
6
Equity in health and health care: the Chinese experience.卫生与医疗保健公平性:中国经验
Soc Sci Med. 1999 Nov;49(10):1349-56. doi: 10.1016/s0277-9536(99)00207-5.
7
A model of the impact of reimbursement schemes on health plan choice.报销方案对健康保险计划选择影响的模型
J Health Econ. 1998 Jun;17(3):297-320. doi: 10.1016/s0167-6296(97)00029-5.
8
Increased cesarean section rates and emerging patterns of health insurance in Shanghai, China.中国上海剖宫产率上升及医疗保险新趋势。
Am J Public Health. 1998 May;88(5):777-80. doi: 10.2105/ajph.88.5.777.
9
Medical savings accounts: lessons from China.医疗储蓄账户:来自中国的经验教训。
Health Aff (Millwood). 1997 Nov-Dec;16(6):244-51. doi: 10.1377/hlthaff.16.6.244.
10
Distribution of medical insurance in China.中国医疗保险的分布情况。
Soc Sci Med. 1995 Oct;41(8):1119-30. doi: 10.1016/0277-9536(94)00420-x.